Actualización en anemia y terapia transfusional

Abstract

Anemia is one of the most prevalent diseases in the general population and is a very frequently found condition in medical and surgical patients in all medical specialties. A good evaluation of its clinical impact and its therapeutic possibilities is essential. Allogenic blood transfusion is a useful procedure in anemia management, although it has important adverse effects. It is the responsibility of the clinician to know and to take into account all the available alternatives for the treatment of anemia. Blood transfusions, erythropoiesis-stimulating agents, iron therapy (oral and endovenous) and other therapeutic alternatives must be rationally used, in accordance with the currently available clinical evidence. This review article summarizes some epidemiological characteristics of anemia, its clinical evaluation and the main therapeutic possibilities based on the present knowledge, placing special emphasis on the critically ill patient.

Experiencia de uso de hierro intravenoso para el tratamiento de la anemia en niños y adolescentes. Respuesta terapéutica y evolución

“…Otra indicación observada fue la escasa respuesta a la transfusión de glóbulos rojos. Se ha demostrado que la administración iv podría disminuir el número de transfusiones de concentrado de hematíes en pacientes politransfundidos (Madrazo et al, 2011;Therapeutics Iniciative, 2015;Butragueño et al, 2019).…”